Literature DB >> 25561880

Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients.

Shaheena Banu1, Nasimudeen R Jabir2, Nanjappa C Manjunath1, Mohd Shahnawaz Khan3, Ghulam Md Ashraf2, Mohammad Amjad Kamal2, Shams Tabrez2.   

Abstract

AIM: The dietary contents have a very important role in the management of metabolic syndrome along with type 2 diabetes mellitus (T2DM). Indian diet contains a large amount of carbohydrates that set off unpredictable blood sugar fluctuations and leads to increased risk of diabetic complications. The aim of the present study was to identify the effect of mulberry tea in the reduction of abnormally high postprandial blood glucose (PPG) levels in T2DM patients.
METHODS: The study design was follow-up T2DM, 20 diabetic patients were given plain tea (control) and 28 diabetic patients were given mulberry tea (test subject) to measure the effect of mulberry tea on fasting blood glucose and PPG levels. Fasting blood glucose samples were collected after a standard breakfast. The PPG levels were recorded after the consumption of 70 ml tea along with 1 teaspoon of sugar after 90 min in all 48 patients.
RESULTS: Fasting blood glucose levels in control and test group samples were found to be 178.55 ± 35.61 and 153.50 ± 48.10, respectively. After the consumption of plain tea and mulberry tea, the PPG values were recorded as 287.20 ± 56.37 and 210.21 ± 58.73, respectively. A highly significant (p < 0.001) change in the PPG level was observed in response to mulberry tea in all the test patients compared with control. Moreover, the effect size was also found to be very large (1.31).
CONCLUSION: Mulberry tea suppresses postprandial rise of blood glucose levels after 90 min of its consumption.

Entities:  

Keywords:  Glucose level; Metabolic disorders; Mulberry tea; Post-prandial hyperglycemia; Type 2 diabetes

Year:  2014        PMID: 25561880      PMCID: PMC4281624          DOI: 10.1016/j.sjbs.2014.04.005

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 1319-562X            Impact factor:   4.219


  41 in total

1.  Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients.

Authors:  Shaheena Banu; Nasimudeen R Jabir; Nanjappa C Manjunath; C K Firoz; Mohammad A Kamal; Mohammad S Khan; Shams Tabrez
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-04       Impact factor: 4.388

2.  Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin-induced diabetic rats.

Authors:  Suman Bala Sharma; Shipra Gupta; Rini Ac; Usha Rani Singh; Reenu Rajpoot; Santosh Kumar Shukla
Journal:  J Pharm Pharmacol       Date:  2010-02       Impact factor: 3.765

3.  Mulberry leaf extract stimulates glucose uptake and GLUT4 translocation in rat adipocytes.

Authors:  Jarinyaporn Naowaboot; Patchareewan Pannangpetch; Veerapol Kukongviriyapan; Auemduan Prawan; Upa Kukongviriyapan; Arunporn Itharat
Journal:  Am J Chin Med       Date:  2012       Impact factor: 4.667

4.  Mulberry leaf extract inhibits the development of atherosclerosis in cholesterol-fed rabbits and in cultured aortic vascular smooth muscle cells.

Authors:  Kuei-Chuan Chan; Mon-Yuan Yang; Ming-Cheng Lin; Yi-Ju Lee; Wen-Chun Chang; Chau-Jong Wang
Journal:  J Agric Food Chem       Date:  2013-03-01       Impact factor: 5.279

Review 5.  Cancer chemoprevention by polyphenols and their potential application as nanomedicine.

Authors:  Shams Tabrez; Medha Priyadarshini; Maryam Urooj; Shazi Shakil; Ghulam Md Ashraf; Mohd Shahnawaz Khan; Mohammad Amjad Kamal; Qamre Alam; Nasimudeen R Jabir; Adel Mohammad Abuzenadah; Adeel G A Chaudhary; Ghazi Abdullah Damanhouri
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

6.  Purified mulberry leaf lectin (MLL) induces apoptosis and cell cycle arrest in human breast cancer and colon cancer cells.

Authors:  Mundekkad Deepa; Thavamani Sureshkumar; Padikara Kutty Satheeshkumar; Sulochana Priya
Journal:  Chem Biol Interact       Date:  2012-09-12       Impact factor: 5.192

Review 7.  Glycemic index and obesity.

Authors:  Janette C Brand-Miller; Susanna H A Holt; Dorota B Pawlak; Joanna McMillan
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

8.  Importance of novel drug delivery systems in herbal medicines.

Authors:  V Kusum Devi; Nimisha Jain; Kusum S Valli
Journal:  Pharmacogn Rev       Date:  2010-01

9.  Anti-hyperglycemic effect of chebulagic acid from the fruits of Terminalia chebula Retz.

Authors:  Yi-Na Huang; Dong-Dong Zhao; Bo Gao; Kai Zhong; Rui-Xue Zhu; Yan Zhang; Wang-Jun Xie; Li-Rong Jia; Hong Gao
Journal:  Int J Mol Sci       Date:  2012-05-22       Impact factor: 6.208

10.  α-Glucosidase inhibitors and their use in clinical practice.

Authors:  Giuseppe Derosa; Pamela Maffioli
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

View more
  13 in total

1.  Effect of Different Nutritional Supplements on Glucose Response of Complete Meals in Two Crossover Studies.

Authors:  Nele Gheldof; Celia Francey; Andreas Rytz; Léonie Egli; Frederik Delodder; Lionel Bovetto; Nathalie Piccardi; Christian Darimont
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

Review 2.  A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile.

Authors:  Wiraphol Phimarn; Kittisak Wichaiyo; Khuntawan Silpsavikul; Bunleu Sungthong; Kritsanee Saramunee
Journal:  Eur J Nutr       Date:  2016-03-14       Impact factor: 5.614

3.  Distribution of Phenolic Contents, Antidiabetic Potentials, Antihypertensive Properties, and Antioxidative Effects of Soursop (Annona muricata L.) Fruit Parts In Vitro.

Authors:  Stephen A Adefegha; Sunday I Oyeleye; Ganiyu Oboh
Journal:  Biochem Res Int       Date:  2015-12-15

4.  Mulberry extract to modULate Blood glucosE Responses in noRmoglYcaemic adults (MULBERRY): study protocol for a randomised controlled trial.

Authors:  Mark Lown; Richard Fuller; Helen Lightowler; Ann Fraser; Andrew Gallagher; Beth Stuart; Christopher D Byrne; George Lewith
Journal:  Trials       Date:  2015-10-28       Impact factor: 2.279

5.  Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double-blind placebo-controlled study.

Authors:  Mark Lown; Richard Fuller; Helen Lightowler; Ann Fraser; Andrew Gallagher; Beth Stuart; Christopher Byrne; George Lewith
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

6.  The effect of 8 plant extracts and combinations on post-prandial blood glucose and insulin responses in healthy adults: a randomized controlled trial.

Authors:  David J Mela; Xiu-Zhen Cao; Rajendra Dobriyal; Mark I Fowler; Li Lin; Manoj Joshi; Theo J P Mulder; Peter G Murray; Harry P F Peters; Mario A Vermeer; Zhang Zhang
Journal:  Nutr Metab (Lond)       Date:  2020-07-06       Impact factor: 4.169

7.  Impact of Maturity of Malay Cherry (Lepisanthes alata) Leaves on the Inhibitory Activity of Starch Hydrolases.

Authors:  Yan Zhang; Yuyang Gui; Dejian Huang
Journal:  Molecules       Date:  2017-05-24       Impact factor: 4.411

Review 8.  Intercultural Usage of Mori Folium: Comparison Review from a Korean Medical Perspective.

Authors:  Byungjin Joh; Eun Sang Jeon; Su Hye Lim; Yu Lee Park; Wansu Park; Han Chae
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

9.  A Synergistic Formulation of Plant Extracts Decreases Postprandial Glucose and Insulin Peaks: Results from Two Randomized, Controlled, Cross-Over Studies Using Real-World Meals.

Authors:  Edyta Adamska-Patruno; Katarzyna Billing-Marczak; Marek Orlowski; Maria Gorska; Marcin Krotkiewski; Adam Kretowski
Journal:  Nutrients       Date:  2018-07-25       Impact factor: 5.717

Review 10.  Mulberry leaves and their potential effects against cardiometabolic risks: a review of chemical compositions, biological properties and clinical efficacy.

Authors:  Thanchanit Thaipitakwong; Surawej Numhom; Pornanong Aramwit
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.